中國國航(00753.HK):控股股東自願承諾不減持公司股份
格隆匯4月8日丨中國國航(00753.HK)公告,2025年4月8日,中國國際航空股份有限公司收到公司控股股東中國航空集團有限公司("中航集團")及其全資子公司中國航空(集團)有限公司("中航有限")出具的關於承諾不減持公司股份的通知,通知主要內容如下:
中航集團及中航有限長期看好中國航空業,基於對公司未來發展前景的信心及對公司內在投資價值的認可,除嚴格履行已就再融資作出的股份限售承諾外,承諾自通知發出日起18個月內,中航集團及中航有限將不以任何方式減持所持有的公司無限售條件流通股股份(包括因本公司資本公積轉增股本、派送股票紅利、配股、增發等事項取得的新增股份)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.